Articles
Entering the world of pharma social media

Entering the world of pharma social media

As the year draws to a close, Rebecca Aris reflects on her first six months of working on a fast-growing social media site. To say that these last six months have flown by would be a massive understatement. Before pharmaphorum I’d spent a few years as...

Articles
Could the private sector save the NHS?

Could the private sector save the NHS?

Inspired by two excellent presentations on NHS reform at a recent PM Society event, Paul Tunnah asks if the private sector could be instrumental in its future. So I’ve dared to mention the dreaded “p” word in reference to the UK’s National Health Service (NHS). If you can keep your hackles in check...

Articles
2010: A pharma odyssey

2010: A pharma odyssey

As another year draws to a close, Paul Tunnah presents his top five highlights from the year and considers what impact these will have for pharma in 2011. Well, that’s it for another year – it’s all over bar one last party and then off we go into January to kick things off again. As usual...

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more